All articles tagged with #transgender health
Nineteen states and D.C. sued the U.S. Department of Health and Human Services over a declaration that labels gender-affirming treatments for youth as unsafe, aiming to restrict access and challenge federal policies, amid ongoing legal and political battles over transgender healthcare rights.
A study published in Nature Medicine reveals that hormone replacement therapy (HRT) for trans women causes biological changes at the molecular level, aligning their protein biomarkers more closely with cisgender women, and potentially improving immune and heart health. The research underscores the biological malleability of adults and suggests a need for personalized HRT monitoring to optimize health outcomes.
A study shows that hormone therapy in trans women causes significant changes in blood proteins, aligning them more closely with cisgender women, which could impact health risks and treatment approaches.
Research from Melbourne shows that gender-affirming hormone therapy can significantly alter body proteins in transgender women to resemble those of cisgender women, potentially impacting health risks and highlighting the need for personalized healthcare approaches.
A study led by Amsterdam UMC found that adding progesterone to feminizing hormone therapy enhances breast growth and is safe for transgender individuals, potentially improving treatment outcomes and reducing the need for surgery.
The University of Michigan Health will cease providing gender-affirming care for minors following a DOJ subpoena and investigation into the prescribing practices, despite medical consensus that such care is essential and evidence-based for transgender youth.
The article discusses unexpected physiological changes experienced by trans women on feminizing hormone therapy, including temperature sensitivity, reduced vein visibility, urinary incontinence, and altered disease risk profiles, highlighting the complex and varied effects of sex hormones on the body.
Hospital staff are encouraging trans and non-binary individuals to attend mammogram appointments for breast cancer screening, emphasizing that early detection saves lives and that everyone's health matters, regardless of gender identity.
Finasteride, a drug known for treating hair loss and enlarged prostate, may also lower cholesterol and reduce heart disease risk, according to recent research. Observational data showed men taking finasteride had lower cholesterol levels, prompting further studies in mice, which confirmed the drug's potential to reduce cholesterol and inflammation. This discovery could benefit not only men but also transgender individuals, who face higher cardiovascular risks. However, finasteride's side effects, including sexual and psychological issues, must be considered, and more human trials are needed to confirm these findings.
A recent study explores how testosterone, particularly in transgender boys undergoing hormone therapy, influences the processing of emotional cues from caregivers and peers during adolescence. Using functional magnetic resonance imaging (fMRI), researchers found that testosterone therapy appears to recalibrate the neural response to emotional cues, reducing the impact of negative familial cues while heightening sensitivity to peer emotions. These findings shed light on the differential impact of testosterone on the brain's processing of emotional cues and its role in the social reorientation process during adolescence.
Half of the World Health Organization's transgender health policy committee members lack medical backgrounds, with most being gender activists. Controversial views on puberty blockers and transitioning have sparked concerns about a potential "trans bias" influencing the WHO's influential recommendations. The panel's composition, including activists, lawyers, and a few medical doctors, has raised questions about conflicts of interest and the balance of perspectives. The guidelines being formulated will shape how countries treat gender dysphoria, with some advocating for controversial treatments for children as young as 13.
A study published in the European Journal of Endocrinology has found that transgender women taking gender-affirming hormones like estrogen are up to 95% more likely to suffer from heart disease compared to cisgender men. The study, which analyzed health data from 2,671 trans individuals in Denmark, also revealed that all trans people were at a significantly higher risk of serious medical conditions, including heart attacks and strokes. Transgender men taking testosterone also had an increased risk of cardiovascular ailments. The study highlights the need for further research to understand the metabolic functions and treatment regimens of transgender individuals.
A new study published in the European Journal of Endocrinology has found that trans women taking gender-affirming hormones are up to 95% more likely to suffer from heart disease compared to men. The study also revealed that all transgender individuals, regardless of their assigned sex at birth or gender identity, are at a significantly increased risk of cardiovascular diseases such as heart attacks, strokes, high blood pressure, and high blood fat and cholesterol levels. Trans men taking testosterone were also found to have a higher risk of heart disease compared to women. The study highlights the importance of further research into the effects of hormone therapy and the need for comprehensive healthcare for transgender individuals.
Many statehouse proposals to restrict gender-affirming care for youths are identical or very similar to some model legislation suggested to lawmakers by conservative interest groups, according to an analysis by the Associated Press. The model bills have similar preambles, including the assertion that the risks of gender-affirming care outweigh its benefits. The AP obtained the texts of more than 130 bills in 40 state legislatures and analyzed them for similarities to model bills touted by the conservative groups Do No Harm and the Family Research Council.